[Ultrafast magnetic resonance tomography changes the standard in pancreas diagnosis].
BACKGROUND
Since the introduction of MRI, including imaging of the hepato-pancreatic duct system (MRCP) and 3D-MR angiography (3D-MRA), new pancreatic diagnostic procedures have been developed.


METHODS
We report on 143 patients with benign and malignant diseases of the pancreas, who only received MRI preoperatively. All radiologic findings were confirmed intraoperatively.


RESULTS
For resectability, MRI obtained sensitivity of 96.0% and specificity of 89.5% and for classification sensitivity of 99.1% and specificity of 95.2%.


CONCLUSIONS
Based on our experience, the benign vs malignant nature of the disease, MRI is a safe and reliable method for pancreatic tumors being able to become the standard diagnostic procedure in the future.
Richter
A
A
Chirurgische Klinik, Universitätsklinikum Mannheim, Klinische Fakultät der Universität Heidelberg, Mannheim. a.richter@stk-hildesheim.de
Gaa
J
J
Niedergethmann
M
M
Georgi
M
M
Trede
M
M
Post
S
S
D003287:Contrast Media; D017352:Echo-Planar Imaging / Q000295:instrumentation; D004867:Equipment Design; D019786:Gadolinium DTPA; D006801:Humans; D007089:Image Enhancement / Q000295:instrumentation*; D007091:Image Processing, Computer-Assisted / Q000295:instrumentation*; D021621:Imaging, Three-Dimensional / Q000295:instrumentation; D018810:Magnetic Resonance Angiography / Q000295:instrumentation; D008279:Magnetic Resonance Imaging / Q000295:instrumentation*; D010179:Pancreas / Q000473:pathology; D010180:Pancreatectomy; D010182:Pancreatic Diseases / Q000175:diagnosis* / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000601:surgery; D011379:Prognosis; D015203:Reproducibility of Results; D013997:Time Factors
D003287:Contrast Media; D019786:Gadolinium DTPA